Opendata, web and dolomites

SLAMseq SIGNED

SLAMseq: Temporal resolution in gene expression profiling across multiple platforms

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "SLAMseq" data sheet

The following table provides information about the project.

Coordinator
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH 

Organization address
address: DR BOHRGASSE 3
city: WIEN
postcode: 1030
website: www.imba.oeaw.ac.at

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-PoC
 Funding Scheme ERC-POC
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH AT (WIEN) coordinator 150˙000.00

Map

 Project objective

Current gene expression profiling by massive parallel RNA sequencing provides insight into relative abundance of RNA molecules but fails to resolve the underlying principles in gene regulation that are reflected in the intracellular kinetics of RNA biogenesis, processing and turnover. In the ERC-StG 'miRLIFE', we have developed a novel technology – SLAMseq – that uncovers a chemically modified nucleoside analog by sequencing. When coupled to metabolic RNA labeling and targeted RNA sequencing, SLAMseq provides unprecedented insights into the intracellular kinetics of gene expression in a rapid, scalable and cost-effective manner. Preliminary data show that the SLAMseq technology can be used to modify other nucleoside analogs and be applied for non-targeted RNA seq protocols. In this PoC, we aim to validate and prove this broader applicability of SLAMseq in order to enable and commercialize genome-wide, time-resolved transcriptomics. In this way, metabolic RNA sequencing will revolutionise biomedical research by providing experimental access to the molecular basis of human malignancies and treatments thereof.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SLAMSEQ" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SLAMSEQ" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PROTECHT (2020)

Providing RObust high TECHnology Tags based on linear carbon nanostructures

Read More  

PROCOMM (2019)

Commercialisation of Proteus

Read More  

TroyCAN (2020)

Redefining the esophageal stem cell niche – towards targeting of squamous cell carcinoma

Read More